A Randomized, Double-Blind, Placebo-Controlled Trial to evaluate the efficacy and safety of TurmXtra 60N in Delayed Onset Muscle Soreness in healthy recreationally active subjects

Inventia Healthcare Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Male and female subjects 18 Ã¢â?¬â?? 35 years of age with a Body Mass Index (BMI) of 18 to 30 kg/m2.
•2.Healthy, moderately active [regular aerobic exercise for at least 150 min per week for past 3 months], non-smoking subjects with no known musculoskeletal pathology.
•3.Subjects who have been vaccinated with COVID 19 (Two doses) vaccine.
•4.Female subjects of childbearing potential must be using a medically acceptable form of birth control.
•5.Results of screening tests within normal range or considered not clinically significant by the Principal Investigator.
•6.Willing to sign the informed consent and comply with study procedure.
•7.willing to abstain from use of analgesics / NSAIDs during entire treatment period

•1.Female subjects, who are pregnant, breast feeding or planning to become pregnant.
•2.Subjects with Covid-19 symptoms.
•3.Subject has known allergy to any compound present in the study product.
•4.Subjects regularly involved in strength training.
•5.History / Presence of frequent use of OTC NSAIDS or / and analgesic agents.
•6.High alcohol intake ( >2 standard drinks per day) or use of recreational drugs (such as cocaine, methamphetamine, marijuana, etc) /Nicotine/Caffeine dependence.
•7.History / presence of psychosis, major depressive disorder or other clinically significant psychiatric disorder.
•8.Participation in any other trials involving investigational or marketed products within 30 days prior to the Screening Visit.
•9.History of surgery or trauma affecting the knee.
•10.History / presence of any neurological or muscular disorders that may affect muscle strength.
•11.History / presence of any chronic illness including but not limited to psychiatric, cardiovascular, pulmonary, neurological, gastrointestinal, hepatic, renal, metabolic, and ophthalmologic disorders; presence of HIV and AIDS; taking regular prescription pharmacological agents.
•12.Subjects on multivitamins/herbal and/or turmeric supplements/ any other wellness product.

发起方